Licensed in New York · NY

GLP-1 weight loss telehealth in New York

FDA-approved brand-name Wegovy®, Zepbound®, and Foundayo™ prescribed by physicians licensed in New York. $29/mo membership — the lowest fee in GLP-1 telehealth. No contracts.

Last clinically reviewed: May 14, 2026 by the Imbue Health Medical Team

How New York licensure works on Imbue

Imbue Health's corporate headquarters is in New York City at 169 Madison Avenue. Physicians are licensed by the New York State Education Department, Office of the Professions.

Every New York prescription Imbue writes goes through a U.S.-licensed, board-certified physician. Medications ship directly from the manufacturer's pharmacy program — NovoCare (Novo Nordisk) for Wegovy® and Oral Wegovy®, LillyDirect (Eli Lilly) for Foundayo™ and Zepbound®. We never use compounding pharmacies.

Major New York metros served include New York City, Brooklyn, Buffalo, Rochester, Syracuse — but we prescribe statewide, not just in major cities.

Eligibility for GLP-1 medication in New York

  • Adults 18 and older residing in New York.
  • BMI ≥30, or BMI ≥25 with at least one weight-related condition (hypertension, type 2 diabetes, dyslipidemia, sleep apnea, cardiovascular disease).
  • No personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
  • Able to receive shipments from NovoCare and LillyDirect at a New York address.
Lowest in industry · $29/mo

Start brand-name GLP-1 in New York at $178/mo

$29/mo Imbue Health membership + brand-name medication shipped directly from NovoCare or LillyDirect to your New York address. No contracts.